Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94323972 | 9432397 | 2 | F | 20130722 | 20130809 | 20130731 | 20130816 | EXP | US-JNJFOC-20130714522 | JANSSEN | 58.12 | YR | M | Y | 93.90000 | KG | 20130816 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94323972 | 9432397 | 1 | PS | XARELTO | 1 | ORAL | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | ||||||
| 94323972 | 9432397 | 2 | SS | XARELTO | 1 | ORAL | N | UNKNOWN | 202439 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94323972 | 9432397 | 1 | Cerebrovascular accident prophylaxis |
| 94323972 | 9432397 | 2 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94323972 | 9432397 | LT |
| 94323972 | 9432397 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94323972 | 9432397 | Embolic stroke |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94323972 | 9432397 | 1 | 20120328 | 20130722 | 0 | |
| 94323972 | 9432397 | 2 | 20120328 | 20130722 | 0 |